Ziopharm Oncology, Inc.
ZIOP
Get informed when a big investor buys or sells
+ FollowMarket Cap$208.12M
Close$
Share Statistics
| Market cap | $208.12 Million |
|---|---|
| Enterprise Value | $208.00 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.2 |
| Beta | 1.69 |
| Outstanding Shares | 2,431,695 |
Return
| Return on Equity | -615.03% |
|---|---|
| Return on Assets | -264.51% |
| Return on Invested Capital | -618.10% |
Valuation & Multiples
| P/E Ratio | -0.91 |
|---|---|
| PEG | 9.68 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 69333.27 |
| Enterprise Value to EBIT | -51.61 |
| Enterprise Value to Net Income | -52 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data